- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05038774
Educational Intervention for Hypertension Management
September 10, 2021 updated by: Prof. Dr. Tariq Ashraf, University of Karachi
Impact of Educational Intervention on Hypertension Management by Primary Care Physician (Pump)
An interventional study is designed and a structured educational session will be conducted regarding the management of Blood pressure for the general physicians of Karachi, Lahore, Peshawar, Islamabad, Multan and Quetta.
The purpose of designing this study is to observe the effect of hypertension educational intervention for general physicians to improve patient outcomes indirectly.
Results of this study may provide a basis for developing a hypertension educational program targeted at general physicians.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Study Procedure
- Screening of General physicians as per inclusion criteria and recruitment of GPs by clinical research associate after obtaining informed consent form.
- GPs will be asked to fill hypertension awareness questionnaire at baseline
- Both group of GPs with the help of clinical research associate will recruit 5 patients from study site.
- After obtaining informed consent, Patient will be asked to fill hypertension awareness questionnaire at baseline or recruitment day and share pictures of 12-hour blood pressure measurement (from digital BP apparatus) with clinical research associate.
- Randomization of GPs will be than in to 2 Groups.
- After randomization, Group 1 GPs will receive (1 day) face to face education and Group 2 GPs will receive print version of education material.
- After GPs education intervention, patients will be invited for regular checkup at GPs clinic.
- Patient will be again asked to fill hypertension awareness questionnaire after 3 months and share pictures of 12-hour blood pressure measurement (from digital BP apparatus) with clinical research associate. (1st, 2nd & 3rd Month).
- GPs will be asked to fill hypertension awareness questionnaire again after 3 months (Post intervention)
Study Type
Interventional
Enrollment (Anticipated)
126
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tariq Ashraf, FCPS
- Phone Number: 03222999914
- Email: tariqash45@gmail.com
Study Locations
-
-
Sindh
-
Karachi, Sindh, Pakistan, 78500
- Karachi institute of heart disease
-
Contact:
- Tariq Ashraf, FCPS
- Phone Number: 03222999914
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- GPs who have at least three years of practice experience in the broad disciplines of primary care using the Numerical Pain Rating (NPR) scale over the past week ≥ 2 on a 0-10 numerical pain scale.
- Patients between 18-60 years.
- Patients with uncontrolled blood pressure according to Pakistan hypertension league guidelines
- Patients with or without angiographically proven coronary, peripheral or cerebral vascular disease.
- Patients must be able to give informed consent and be able to read and comprehend in the Urdu (National Language)
- Patients must have a digital BP apparatus at home.
- Patients must have a phone with camera and internet.
Exclusion Criteria:
- GPs who had attended a planned Hypertension educational program during the last 6 months.
- Patients with a recognized psychiatric disorder as per the Diagnostic and Statistical Manual of Mental Disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Interventional group
GPs of the Interventional group will receive (1 day) face to face education with structured educational material on strategies of hypertension management by a senior cardiologist.
|
|
|
Active Comparator: Control group
GPs of the Control group will receive print version of education material (Structured educational material) on strategies of structured hypertension management.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Pressure
Time Frame: 3 Months
|
Pre & Post change in the blood pressure control rate.
Defined as percentage of patients with an average 12-hour blood pressure <130/80 mmHg.
|
3 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge of GPs about Hypertension Management
Time Frame: 3 Months
|
Pre & Post knowledge enhancement of GPs regarding hypertension management.
|
3 Months
|
|
Knowledge of Patients about Hypertension Management
Time Frame: 3 Months
|
Pre & Post knowledge enhancement of patients regarding hypertension
|
3 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002 Nov 2;360(9343):1347-60. doi: 10.1016/S0140-6736(02)11403-6.
- Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2004 Apr;35(4):1024.
- Tu K, Chen Z, Lipscombe LL; Canadian Hypertension Education Program Outcomes Research Taskforce. Prevalence and incidence of hypertension from 1995 to 2005: a population-based study. CMAJ. 2008 May 20;178(11):1429-35. doi: 10.1503/cmaj.071283.
- Marques-Vidal P, Tuomilehto J. Hypertension awareness, treatment and control in the community: is the 'rule of halves' still valid? J Hum Hypertens. 1997 Apr;11(4):213-20. doi: 10.1038/sj.jhh.1000426.
- Primatesta P, Brookes M, Poulter NR. Improved hypertension management and control: results from the health survey for England 1998. Hypertension. 2001 Oct;38(4):827-32.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 30, 2021
Primary Completion (Anticipated)
December 31, 2022
Study Completion (Anticipated)
December 31, 2022
Study Registration Dates
First Submitted
August 22, 2021
First Submitted That Met QC Criteria
September 2, 2021
First Posted (Actual)
September 9, 2021
Study Record Updates
Last Update Posted (Actual)
September 17, 2021
Last Update Submitted That Met QC Criteria
September 10, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PUMPKG
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on Face to face Educational Training
-
University of BirminghamHeart of England NHS Trust; Calderdale and Huddersfield NHS Foundation Trust; Resuscitation Council UKCompletedCardiac Arrest
-
University of VermontNot yet recruitingOlder Adults (60 - 85 Years Old)
-
Marmara UniversityCompleted
-
Shahid Beheshti University of Medical SciencesUnknownArrythmiaIran, Islamic Republic of
-
Sakarya UniversityCompleted
-
Saglik Bilimleri Universitesi Gulhane Tip FakultesiCompleted
-
Radboud University Medical CenterCompletedCardiac Arrest | Out-Of-Hospital Cardiac Arrest | Cardiopulmonary ArrestNetherlands
-
Azienda Socio Sanitaria Territoriale di LodiNot yet recruiting
-
University of Maryland, College ParkEnrolling by invitationGender Identity | Sexual OrientationUnited States
-
Abant Izzet Baysal UniversityNot yet recruiting